接头 CAR 共表达在淋巴瘤单一及双重抗原丢失后保留 CAR-T 细胞疗效 Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma. PubMed 2025/10/24 发表Mol TherQ1 · IF 11.4(JCR 2025) 靶点:CD19靶点:CD20靶点:ROR1技术:CAR-T技术:双特异性抗体淋巴瘤
慢性淋巴细胞白血病中的 Richter 转化:当前治疗挑战与不断演变的疗法 Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies. PubMed 2025/09/08 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD19靶点:CD20靶点:ROR1技术:CAR-T技术:造血干细胞技术:双特异性抗体
2022 年套细胞淋巴瘤:分子发病机制、风险分层、临床策略及当前与新型治疗的综合更新 Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatment PubMed 2022/05/01 发表Am J HematolQ1 · IF 9.4(JCR 2025) 靶点:CD19靶点:CD20靶点:CD70技术:CAR-T技术:双特异性抗体套细胞淋巴瘤淋巴瘤